Lundbeck (Exclusive Worldwide License To IMR-687, A Hemoglobinopathy Drug) is Buildings and Property in United States that focus on Exclusive worldwide license business. They cover business area such as exclusive worldwide license, sickle cell disease.
-
Exclusive Worldwide License
-
6 Parkway North
Deerfield, IL 60015
United States
Private
exclusive worldwide licensesickle cell disease
* We use standard office opening hours in near Lundbeck (Exclusive Worldwide License To IMR-687, A Hemoglobinopathy Drug)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Lundbeck (Exclusive Worldwide License To IMR-687, A Hemoglobinopathy Drug) is Buildings and Property business from United States that founded in - ( years old in ), Lundbeck (Exclusive Worldwide License To IMR-687, A Hemoglobinopathy Drug) business is focusing on Exclusive Worldwide License.
Lundbeck (Exclusive Worldwide License To IMR-687, A Hemoglobinopathy Drug) headquarter office and corporate office address is located in 6 Parkway North Deerfield, IL 60015 United States.
Lundbeck (Exclusive Worldwide License To IMR-687, A Hemoglobinopathy Drug) was founded in United States.
In , Lundbeck (Exclusive Worldwide License To IMR-687, A Hemoglobinopathy Drug) is currently focus on Exclusive worldwide license sector.
Above is snippet of Google Trends for "Exclusive worldwide license" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Lundbeck (Exclusive Worldwide License To IMR-687, A Hemoglobinopathy Drug), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
